Folinic acid administration after MTX GVHD prophylaxis in pediatric allo-SCT
Bone Marrow Transplantation, 05/25/2012Hudspeth MP et al.
Increased likelihood of receiving day +11 MTX suggests that Folinic acid (FA) ameliorates MTX toxicity, such as severe mucositis. FA administration for MTX GVHD prophylaxis should be studied in a prospective, randomized fashion.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.